The Cardiac Assist Devices Market is Expected to Grow at a CAGR of Over 9% During the Period 2019–2025.
Speak directly to the analyst to clarify any post sales queries you may have.
The cardiac assist devices market is expected to observe significant growth on account of the growing incidence of congestive heart failures worldwide, especially in the geriatric population. With increased awareness of heart failures among patients and the availability of advanced treatment options, the market is likely to witness growth during the forecast period.
The emergence of next-generation cardiac assist devices is expected to fuel industry growth during the forecast period. The industry has witnessed the launch of several advanced and innovative heart assist devices with major changes in product designs and material usage. The introduction of less invasive devices by surgeons to perform left ventricular assist devices (LVAD) implant surgeries efficiently is leading to promising post-surgical outcomes.
Moreover, the global cardiac assist devices market is likely to grow during the forecast period due to increasing technological advancements, new product approvals, increasing elderly population, improvements in reimbursement policies for heart failures, and associated comorbidities. Vendors are likely to focus on addressing unmet patient need as the demands for innovative cardiac assist devices is growing due to promising clinical outcomes, thereby increasing opportunities for vendors.
The following factors are likely to contribute to the growth of the cardiac assist devices market during the forecast period:
- Growing Global Incidence of Heart Failure
- Shortage of Donor Hearts & Increasing Patient Waiting List for Heart Transplantation
- Increasing demand for Shared Care Centers & their Importance Post-LVAD Implantation
- Technological Advancements
- New Product Approvals and Line Extensions for Existing Commercial Cardiac Assist Devices
The study considers the present scenario of the cardiac assist devices market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.
Global Cardiac Assist Devices Market: Segmentation
This research report includes detailed segmentation by Application, Products, End-users, and Geography. The application of bridge to transplant (BTT) is enhancing the quality of life and survival chances of patients. The segment is expected to grow steadily due to advances in technology. The entry of advanced and innovative products from first-generation pulsatile flow cardiac assist devices to third-generation continuous flow devices is immensely influencing market growth prospects. However, the segment is likely to witness a decline during the forecast due to the increasing usage of cardiac assist devices as a destination therapy for treating advanced heart failure.
Left ventricular assist devices (LVAD) are predominantly used to bridge to transplant and destination therapy compared to other devices. The usage of LVAD has significantly improved the survival rate among patients undergoing heart transplantation. The application of LVADs in patients requiring cardiac support for longer duration enhances the quality of life and survival chances. These factors are likely to influence patients to prefer LVAD implants, thereby bolstering the demand for LVADs.
Intra-aortic balloon pumps (IABP) are considered to be the first line of treatment, especially in low and middle-income countries, and help treat the patient at critical stages. The segment is expected to grow due to several surgeons recommending IABP for treating advanced heart failures. IABPs provide safer use and earlier intervention to provide hemodynamic support and has minimal complications than other cardiac assist devices.
The hospital segment is expected to dominate the market during the forecast period, as the number of hospitals offering cardiac care is relatively high than in other healthcare settings. Patients prefer undergoing advanced heart failure treatment in hospitals due to their convenient locations and ease of accessibility. Moreover, the aging population and shortage of heart donors are other major factors likely to drive the segment growth.
Specialty cardiac centers (SSCs) are solely dedicated to treating patients suffering from several CVDs, such as vascular stenosis and heart failure. The segment is expected to grow at the fastest CAGR due to the availability of sophisticated infrastructure related to the diagnosis and high-quality treatment of CVDs in standalone cardiology centers.
- Market Segmentation by Application
- Bridge to Transplant
- Destination Therapy
- Others
- Market Segmentation by Product
- Intra-aortic Balloon Pump (IABP)
- Ventricular Assist Devices (VADs)
- Left Ventricular Assist Devices (LVADs)
- Other VADs
- Total Artificial Heart (TAH)
- Market Segmentation by End-user
- Hospitals
- Special Cardiac Centers
Insights by Geography
The North American market is expected to grow at the fastest CAGR due to favorable patient demographics, availability of skilled surgeons, and favorable reimbursement coverage. The increasing prevalence of obesity and diabetes, coupled with the aging population, has increased heart failures, which are expected to bolster the market. In Europe, the market is likely to grow because of the increasing geriatric population with heart diseases and high awareness of the advantages of cardiac assist devices. Further, increased government investments for such devices are likely to boost industry growth. Germany, the UK, and France are the key countries in the region as they invest the highest in R&D activities than other European countries. The APAC market is expected to grow at a moderate rate due to the increased healthcare expenditure, coupled with a high prevalence of CVDs. Favorable government policies and increased vendor initiatives in spreading awareness of stents are the other primary factors likely to influence the industry.
Market Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- APAC
- Japan
- China
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- Turkey
- Saudi Arabia
Insights by Vendors
The global cardiac assist devices market is highly consolidated with major players accounting for a significant share of the industry. However, there are considerable growth opportunities for new entrants. Several investigational and small med-tech companies are expected to offer innovative products and technologies. The leading players are focusing on implementing several strategies such as product launches and approvals, acquisitions, and an increase in R&D investment to enhance their market share. Moreover, they focus on expansion in existing and new industries to cater to the needs of growing customer base, widen their product portfolios, and boost their production capabilities to gain traction from end-users. Leading players are likely to dominate the industry on account of their strong presence and surgeons’ endorsement for their products due to the availability of abundant clinical data and efficacy.
Key Vendors
- Abbott
- Medtronic
Other Vendors
- Abiomed
- Berlin Heart
- Getinge
- SynCardia
- Teleflex
- ZEON MEDICAL
- Tokai Medical Products
- SENKO MEDICAL INSTRUMENT
- Insightra Medical
- ReliantHeart
- PulseCath
- Jarvik Heart
Key Market Insights
- The analysis of the cardiac assist devices market provides market sizing and growth opportunities for the period 2019–2025.
- Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market.
- Includes a detailed analysis of challenges and investment opportunities in the industry.
- Delivers a complete overview of market segments and the regional outlook of the cardiac assist devices market.
- Offers an exhaustive summary of the vendor landscape, competitive analysis, and key market strategies to gain a competitive advantage in the market.
Table of Contents
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusion
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.4 Market Segmentation
4.4.1 Product
4.4.2 Application
4.4.3 End-users
4.4.4 Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Background
7.1.2 Cardiac Assist Devices
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Growing Global Prevalence/Incidence of Heart Failure
8.1.2 Shortage of Donor Hearts & Increasing Patient Waiting List for Heart Transplantation
8.1.3 Growing Demand for Shared Care Centers & their Importance Post-LVAD
8.2 Market Restraints
8.2.1 High Cost of Cardiac Assist Devices
8.2.2 Stringent & Time-consuming Regulatory Approvals
8.2.3 Complications & Risks Associated with Cardiac Assist Devices
8.3 Market Opportunities and Trends
8.3.1 Technological Advancements
8.3.2 Promising Investigational Cardiac Assist Devices
8.3.3 New Product Approvals and Line Extensions for Existing Commercial Cardiac Assist Devices
9 Market Landscape
9.1 Market Overview
9.2 Market Size and Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 Product
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
11 Ventricular Assist Devices
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.2.1 Market Size & Forecast
11.3 Ventricular Assist Devices Market Segmentation by Product
11.4 Left-Ventricular Assist Devices
11.4.1 Market Overview
11.4.2 Market Size & Forecast
11.5 Other Ventricular Assist Devices
11.5.1 Market Overview
11.5.2 Market Size & Forecast
12 Intra-Aortic Balloon Pump Therapy Devices
12.1 Market Overview
12.2 Market Size & Forecast
13 Total Artificial Heart
13.1 Market Overview
13.2 Market Size & Forecast
14 Application
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Bridge to Transplantation (BTT)
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Destination Therapy (DT)
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Other Applications
14.5.1 Market Overview
14.5.2 Market Size & Forecast
15 End-Users
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Hospitals
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Specialty Cardiac Centers
15.4.1 Market Overview
15.4.2 Market Size & Forecast
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 US: Market Size & Forecast
17.3.2 Canada: Market Size & Forecast
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Germany: Market Size & Forecast
18.3.2 France: Market Size & Forecast
18.3.3 UK: Market Size & Forecast
18.3.4 Spain: Market Size & Forecast
18.3.5 Italy: Market Size & Forecast
19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Japan: Market Size & Forecast
19.3.2 China: Market Size & Forecast
19.3.3 Australia: Market Size & Forecast
19.3.4 South Korea: Market Size & Forecast
19.3.5 India: Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Brazil: Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast
21 Middle East and Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.2 Key Countries
21.2.1 Turkey: Market Size & Forecast
21.2.2 Saudi Arabia: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Analysis
22.2.1 Ventricular Assist Devices
22.2.2 IABP
22.2.3 Total Artificial Heart
23 Key Company Profiles
23.1 Abbott
23.1.1 Business Overview
23.1.2 Abbott in Global Cardiac Assist Devices Market
23.1.3 Major Product Offerings
23.1.4 Key Strengths
23.1.5 Key Strategies
23.1.6 Key Opportunities
23.2 Medtronic
23.2.1 Business Overview
23.2.2 Medtronic in Global Cardiac Assist Devices Market
23.2.3 Major Product Offerings
23.2.4 Key Strengths
23.2.5 Key Strategies
23.2.6 Key Opportunities
24 Other Prominent Vendors
24.1 Abiomed
24.1.1 Business Overview
24.1.2 Product Offerings
24.1.3 Key Strengths
24.1.4 Key Strategies
24.1.5 Key Opportunities
24.2 Berlin Heart
24.2.1 Business Overview
24.2.2 Product Offerings
24.2.3 Key Strengths
24.2.4 Key Strategies
24.2.5 Key Opportunities
24.3 Getinge
24.3.1 Business Overview
24.3.2 Product Offerings
24.3.3 Key Strengths
24.3.4 Key Strategies
24.3.5 Key Opportunities
24.4 Syncardia
24.4.1 Business Overview
24.4.2 Product Offerings
24.4.3 Key Strengths
24.4.4 Key Strategies
24.4.5 Key Opportunities
24.5 Teleflex
24.5.1 Business Overview
24.5.2 Product Offerings
24.5.3 Key Strengths
24.5.4 Key Strategies
24.5.5 Key Opportunities
24.6 Zeon Medical
24.6.1 Business Overview
24.6.2 Product Offerings
24.6.3 Key Strengths
24.6.4 Key Strategies
24.6.5 Key Opportunities
24.7 Tokai Medical Products
24.7.1 Business Overview
24.7.2 Product Offerings
24.7.3 Key Strengths
24.7.4 Key Strategies
24.7.5 Key Opportunities
24.8 SENKO Medical Instrument
24.8.1 Business Overview
24.8.2 Product Offerings
24.8.3 Key Strengths
24.8.4 Key Strategies
24.8.5 Key Opportunities
24.9 Insightra Medical
24.9.1 Business Overview
24.9.2 Product Offerings
24.9.3 Key Strengths
24.9.4 Key Strategies
24.9.5 Key Opportunities
24.10 Reliantheart
24.10.1 Business Overview
24.10.2 Product Offerings
24.10.3 Key Strengths
24.10.4 Key Strategies
24.10.5 Key Opportunities
24.11 Pulsecath
24.11.1 Business Overview
24.11.2 Product Offerings
24.11.3 Key Strengths
24.11.4 Key Strategies
24.11.5 Key Opportunities
24.12 Jarvik Heart
24.12.1 Business Overview
24.12.2 Product Offerings
24.12.3 Key Strengths
24.12.4 Key Strategies
24.12.5 Key Opportunities
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
25.3 Quantitative Summary
25.3.1 Product
25.3.2 Application
25.3.3 End-users
25.3.4 Geography
26 Appendix
26.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Cardiac Assist Devices Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Various Treatment Options for Heart Failure
Exhibit 4 Impact of Growing Global Prevalence/Incidence of Heart Failure
Exhibit 5 Global Prevalence of Heart Failure in Adults
Exhibit 6 Prevalence of Heart Failure in Selected Countries 2017
Exhibit 7 Impact of Shortage of Donor Hearts & Increasing Patient Waiting List for Heart Transplantation
Exhibit 8 Heart Transplantation Waiting List in Key Countries/Regions 2017
Exhibit 9 Number of Heart Transplantations Performed in 2017
Exhibit 10 Comparison of Number of Heart Transplantations Performed in India 1994-2014 Versus 2016-2017
Exhibit 11 Impact of Growing Demand for Shared Care Centers & their Importance Post-LVAD Implantation
Exhibit 12 Shared Care Model Framework
Exhibit 13 Impact of High Cost of Cardiac Assist Devices
Exhibit 14 Impact of Stringent & Time-consuming Regulatory Approvals
Exhibit 15 Impact of Complications & Risks Associated with Cardiac Assist Devices
Exhibit 16 Impact of Technological Advancements
Exhibit 17 First-generation Cardiac Assist Devices
Exhibit 18 Impact of Promising Investigational Cardiac Assist Devices
Exhibit 19 Impact of New Product Approvals and Line Extensions for Existing Commercial Cardiac Assist Devices
Exhibit 20 Global Cardiac Assist Devices Market 2019−2025 ($ million)
Exhibit 21 Five Force Analysis 2019
Exhibit 22 Incremental Growth by Product 2019 & 2025
Exhibit 23 Global Cardiac Assist Devices Market by Product
Exhibit 24 Global Cardiac Assist Devices Market by Product 2019 & 2025 (%)
Exhibit 25 Global Cardiac Assist Devices Market by Product: Incremental Growth
Exhibit 26 Global Cardiac Assist Devices Market by Product: Absolute Growth
Exhibit 27 Incremental Growth by Product 2019 & 2025
Exhibit 28 Global Ventricular Assist Devices Market: Incremental Growth Versus Absolute Growth Comparison
Exhibit 29 Global Ventricular Assist Devices Market 2019−2025 ($ million)
Exhibit 30 Global Ventricular Assist Devices Market by Product
Exhibit 31 Global Ventricular Assist Devices Market by Product 2019 & 2025 (%)
Exhibit 32 Global Ventricular Assist Devices Market by Product 2019-2025 ($ million)
Exhibit 33 Global Ventricular Assist Devices Market by Product 2019-2025 (%)
Exhibit 34 Global LVADs Market 2019−2025 ($ million)
Exhibit 35 Global Other Ventricular Assist Devices Market 2019−2025 ($ million)
Exhibit 36 Global Intra-aortic Balloon Pump Therapy Devices Market: Incremental Growth Versus Absolute Growth Comparison
Exhibit 37 Global Intra-aortic Balloon Pump Therapy Devices Market 2019−2025 ($ million)
Exhibit 38 Global Total Artificial Heart Market: Incremental Growth Versus Absolute Growth Comparison
Exhibit 39 Global Total Artificial Heart Market 2019−2025 ($ million)
Exhibit 40 Incremental Growth by Application 2019 & 2025
Exhibit 41 Global Cardiac Assist Devices Market by Application
Exhibit 42 Global Cardiac Assist Devices Market by Application 2019 & 2025 (%)
Exhibit 43 Global Cardiac Assist Devices Market by Application: Incremental Growth
Exhibit 44 Global Cardiac Assist Devices Market by Application: Absolute Growth
Exhibit 45 Global Cardiac Assist Devices Market by Bridge to Transplant: Incremental Growth Versus Absolute Growth
Exhibit 46 Global Cardiac Assist Devices Market by Bridge to Transplantation 2019−2025 ($ million)
Exhibit 47 Global Cardiac Assist Devices Market by Destination Therapy: Incremental Growth Versus Absolute Growth
Exhibit 48 Global Cardiac Assist Devices Market by Destination Therapy 2019−2025 ($ million)
Exhibit 49 Global Cardiac Assist Devices Market by Other Applications: Incremental Growth Versus Absolute Growth Comparison
Exhibit 50 Global Cardiac Assist Devices Market by Other Applications 2019−2025 ($ million)
Exhibit 51 Incremental Growth by End-users 2019 & 2025
Exhibit 52 Global Cardiac Assist Devices Market by End-users
Exhibit 53 Global Cardiac Assist Devices Market by End-users 2019 & 2025 (%)
Exhibit 54 Global Cardiac Assist Devices Market by End-users: Incremental Growth
Exhibit 55 Global Cardiac Assist Devices Market by End-users: Absolute Growth
Exhibit 56 Global Cardiac Assist Devices Market by Hospitals: Incremental Growth Versus Absolute Growth Comparison
Exhibit 57 Global Cardiac Assist Devices Market by Hospitals 2019−2025 ($ million)
Exhibit 58 Global Cardiac Assist Devices Market by Specialty Cardiac Centers: Incremental Growth Versus Absolute Growth Comparison
Exhibit 59 Global Cardiac Assist Devices Market by Specialty Cardiac Centers 2019−2025 ($ million)
Exhibit 60 Incremental Growth by Geography 2019 & 2025
Exhibit 61 Global Cardiac Assist Devices Market by Geography
Exhibit 62 Global Cardiac Assist Devices Market by Geography 2019 & 2025 (%)
Exhibit 63 Global Cardiac Assist Devices Market by Geography: Incremental Growth
Exhibit 64 Global Cardiac Assist Devices Market by Geography: Incremental Growth
Exhibit 65 Cardiac Assist Devices Market in North America: Incremental Growth Versus Absolute Growth Comparison
Exhibit 66 Cardiac Assist Devices Market in North America 2019–2025 ($ million)
Exhibit 67 Incremental Growth in North America 2019 & 2025
Exhibit 68 Cardiac Assist Devices Market in US 2019–2025 ($ million)
Exhibit 69 Cardiac Assist Devices Market in Canada 2019–2025 ($ million)
Exhibit 70 Cardiac Assist Devices Market in Europe: Incremental Growth Versus Absolute Growth Comparison
Exhibit 71 Cardiac Assist Devices Market in Europe 2019–2025 ($ million)
Exhibit 72 Incremental Growth in Europe 2019 & 2025
Exhibit 73 Cardiac Assist Devices Market in Germany 2019–2025 ($ million)
Exhibit 74 Cardiac Assist Devices Market in France 2019–2025 ($ million)
Exhibit 75 Cardiac Assist Devices Market in UK 2019–2025 ($ million)
Exhibit 76 Cardiac Assist Devices Market in Spain 2019–2025 ($ million)
Exhibit 77 Cardiac Assist Devices Market in Italy 2019–2025 ($ million)
Exhibit 78 Cardiac Assist Devices Market in APAC: Incremental Growth Versus Absolute Growth Comparison
Exhibit 79 Cardiac Assist Devices Market in APAC 2019–2025 ($ million)
Exhibit 80 Incremental Growth in APAC 2019 & 2025
Exhibit 81 Cardiac Assist Devices Market in Japan 2019–2025 ($ million)
Exhibit 82 Cardiac Assist Devices Market in China 2019–2025 ($ million)
Exhibit 83 Cardiac Assist Devices Market in Australia 2019–2025 ($ million)
Exhibit 84 Cardiac Assist Devices Market in South Korea 2019–2025 ($ million)
Exhibit 85 Cardiac Assist Devices Market in India 2019–2025 ($ million)
Exhibit 86 Cardiac Assist Devices Market in Latin America: Incremental Versus Absolute Growth Comparison
Exhibit 87 Cardiac Assist Devices Market in Latin America 2019–2025 ($ million)
Exhibit 88 Incremental Growth in Latin America 2019 & 2025
Exhibit 89 Cardiac Assist Devices Market in Brazil 2019–2025 ($ million)
Exhibit 90 Cardiac Assist Devices Market in Mexico 2019–2025 ($ million)
Exhibit 91 Cardiac Assist Devices Market in Argentina 2019–2025 ($ million)
Exhibit 92 Cardiac Assist Devices Market in Middle East & Africa: Incremental Growth Versus Absolute Growth Comparison
Exhibit 93 Cardiac Assist Devices Market in Middle East and Africa 2019–2025 ($ million)
Exhibit 94 Incremental Growth in Middle East and Africa 2019 & 2025
Exhibit 95 Cardiac Assist Devices Market in Turkey 2019–2025 ($ million)
Exhibit 96 Cardiac Assist Devices Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 97 Abbott: R&D Expenditure in FY2016, FY2017 and FY2018 ($ million)
Exhibit 98 Abbott: Sales Breakdown by Segments in FY2017 and FY2018 ($ million)
Exhibit 99 Abbott Sales Breakdown by Geography 2018 (%)
Exhibit 100 Medtronic Sales Breakdown by Segments FY2018 (%)
Exhibit 101 Medtronic R&D Expenditure FY2016-FY2018 ($ million)
Exhibit 102 Medtronic Revenue Breakdown by Geography FY2018 (%)
Exhibit 103 Medtronic Revenue by Business Segments in FY2017 and FY2018 ($ million)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 New York Heart Association Classification of Heart Failure
Table 4 Potential Benefits of Shared Care Model for Various Stakeholders
Table 5 Cost of Various Cardiac Assist Devices
Table 6 Complications Related to Cardiac Assist Devices & Their Prevalence
Table 7 Popular First, Second, and Third-generation Cardiac Assist Devices
Table 8 List of Promising Investigational Cardiac Assist Devices
Table 9 List of Cardiac Assist Devices Approved/Launched in Various Countries
Table 10 List of Cardiac Assist Devices Approved for New Indications
Table 11 Global Ventricular Assist Market: Vendors Ranking
Table 12 Global Ventricular Assist Market: Vendors Ranking
Table 13 Abbott Group: Product Offerings
Table 14 Medtronic: Major Clinical Trials for Heart Failure Treatment
Table 15 Medtronic: Product Offerings
Table 16 Abiomed: Key Product Offerings
Table 17 Berlin Heart: Key Product Offerings
Table 18 Getinge: Key Product Offerings
Table 19 SynCardia: Key Product Offerings
Table 20 Teleflex: Key Product Offerings
Table 21 ZEON MEDICAL: Key Product Offerings
Table 22 Tokai Medical Products: Key Product Offerings
Table 23 SENKO MEDICAL INSTRUMENT: Key Product Offerings
Table 24 Insightra Medical: Key Product Offerings
Table 25 ReliantHeart: Key Product Offerings
Table 26 PulseCath: Key Product Offerings
Table 27 Jarvik Heart: Key Product Offerings
Table 28 Global Cardiac Assist Devices Market by Product ($ million)
Table 29 Global Cardiac Assist Devices Market by Product (%)
Table 30 Global Cardiac Assist Devices Market by Application ($ million)
Table 31 Global Cardiac Assist Devices Market by Application (%)
Table 32 Global Cardiac Assist Devices Market by End-users ($ million)
Table 33 Global Cardiac Assist Devices Market by End-users (%)
Table 34 Global Cardiac Assist Devices Market by Geography ($ million)
Table 35 Global Cardiac Assist Devices Market by Geography (%)"
Samples
LOADING...
Companies Mentioned
- Abbott
- Medtronic
- Abiomed
- Berlin Heart
- Getinge
- SynCardia
- Teleflex
- ZEON MEDICAL
- Tokai Medical Products
- SENKO MEDICAL INSTRUMENT
- Insightra Medical
- ReliantHeart
- PulseCath
- Jarvik Heart
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
